Cargando…

Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders

Detalles Bibliográficos
Autores principales:	Villoutreix, Bruno O., Beaune, Philippe H., Tamouza, Ryad, Krishnamoorthy, Rajagopal, Leboyer, Marion
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315962/ https://www.ncbi.nlm.nih.gov/pubmed/32593662 http://dx.doi.org/10.1016/j.drudis.2020.06.022

Ejemplares similares

Chemoinformatic Analysis of Psychotropic and Antihistaminic Drugs in the Light of Experimental Anti-SARS-CoV-2 Activities
por: Villoutreix, Bruno O, et al.
Publicado: (2021)

Understanding the genetic contribution of the human leukocyte antigen system to common major psychiatric disorders in a world pandemic context
por: Tamouza, Ryad, et al.
Publicado: (2021)

IL6/IL6R genetic diversity and plasma IL6 levels in bipolar disorder: An Indo-French study
por: Sundaresh, Aparna, et al.
Publicado: (2019)

HLA-class II haplotypes and Autism Spectrum Disorders
por: Bennabi, Meriem, et al.
Publicado: (2018)

A bipolar disorder patient becoming asymptomatic after adjunctive anti-filiarasis treatment: a case report
por: Hamdani, Nora, et al.
Publicado: (2013)

Antihistamine and cationic amphiphilic drugs, old molecules as new tools against the COVID-19?
por: Gitahy Falcao Faria, Clara, et al.
Publicado: (2021)

The Clinical Challenge of Autoimmune Psychosis: Learning from Anti-NMDA Receptor Autoantibodies
por: Ellul, Pierre, et al.
Publicado: (2017)

DNA hydrolysing IgG catalytic antibodies: an emerging link between psychoses and autoimmunity
por: Ramesh, Rajendran, et al.
Publicado: (2021)

Association between CRP genetic diversity and bipolar disorder comorbid complications
por: Boukouaci, Wahid, et al.
Publicado: (2018)

Dectin-1 Polymorphism: A Genetic Disease Specifier in Autism Spectrum Disorders?
por: Bennabi, Meriem, et al.
Publicado: (2015)

Correction: Dectin-1 Polymorphism: A Genetic Disease Specifier in Autism Spectrum Disorders?
por: Bennabi, Meriem, et al.
Publicado: (2019)

Combined Effect of TLR2 Gene Polymorphism and Early Life Stress on the Age at Onset of Bipolar Disorders
por: Oliveira, José, et al.
Publicado: (2015)

Toxoplasma gondii exposure may modulate the influence of TLR2 genetic variation on bipolar disorder: a gene–environment interaction study
por: Oliveira, José, et al.
Publicado: (2016)

Immuno-psychiatry: an agenda for clinical practice and innovative research
por: Leboyer, Marion, et al.
Publicado: (2016)

Persistence of dysfunctional natural killer cells in adults with high-functioning autism spectrum disorders: stigma/consequence of unresolved early infectious events?
por: Bennabi, Meriem, et al.
Publicado: (2019)

Drug repurposing strategies for COVID-19
por: Senanayake, Suranga L
Publicado: (2020)

Advances in Antifungal Development: Discovery of New Drugs and Drug Repurposing
por: Kim, Jong H., et al.
Publicado: (2022)

Immunoglobulin sub-class distribution in bipolar disorder and schizophrenia: potential relationship with latent Toxoplasma Gondii infection
por: Hamdani, Nora, et al.
Publicado: (2018)

The wisdom of crowds and the repurposing of artesunate as an anticancer drug
por: Augustin, Yolanda, et al.
Publicado: (2015)

Biocomputing drug repurposing toward targeted therapies
por: Cardone, Luca
Publicado: (2016)

Trends and Applications in Computationally Driven Drug Repurposing
por: Pinzi, Luca, et al.
Publicado: (2023)

Identification of inflammatory subgroups of schizophrenia and bipolar disorder patients with HERV-W ENV antigenemia by unsupervised cluster analysis
por: Tamouza, Ryad, et al.
Publicado: (2021)

Correction: Identification of inflammatory subgroups of schizophrenia and bipolar disorder patients with HERV-W ENV antigenemia by unsupervised cluster analysis
por: Tamouza, Ryad, et al.
Publicado: (2021)

New opportunities for kinase drug repurposing and target discovery
por: Knapp, Stefan
Publicado: (2018)

Repurposing Cardio-Metabolic Drugs to Fight Covid19
por: Battistoni, Allegra, et al.
Publicado: (2021)

Drug repurposing: a nexus of innovation, science, and potential
por: De Rosa, Maria Cristina, et al.
Publicado: (2023)

Prescribing opioids and psychotropic drugs in pregnancy
por: Patrick, Stephen W, et al.
Publicado: (2017)

Viewpoint | European COVID-19 exit strategy for people with severe mental disorders: Too little, but not yet too late
por: De Picker, Livia J., et al.
Publicado: (2021)

Repurposing paclitaxel for the treatment of fibrosis: indication discovery for existing drugs
por: Chen, Xiao-Wu, et al.
Publicado: (2015)

Repurposing of FDA-approved drugs against cancer – focus on metastasis
por: Ozsvári, Béla, et al.
Publicado: (2016)

Drug Repurposing and DNA Damage in Cancer Treatment: Facts and Misconceptions
por: Sertedaki, Eleni, et al.
Publicado: (2020)

Precision psychiatry with immunological and cognitive biomarkers: a multi-domain prediction for the diagnosis of bipolar disorder or schizophrenia using machine learning
por: Fernandes, Brisa S., et al.
Publicado: (2020)

Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis
por: Vai, Benedetta, et al.
Publicado: (2021)

A double amino-acid change in the HLA-A peptide-binding groove is associated with response to psychotropic treatment in patients with schizophrenia
por: Le Clerc, S, et al.
Publicado: (2015)

Repurposing A549 Adenocarcinoma Cells: New Options for Drug Discovery
por: Garcia-de-Alba, Carolina
Publicado: (2021)

Repurposing an ‘Old’ Drug for the Treatment of COVID-19-Related Cytokine Storm
por: Pontali, Emanuele, et al.
Publicado: (2023)

Prescribing issues in older adults living with HIV: thinking beyond drug–drug interactions with antiretroviral drugs
por: Livio, Françoise, et al.
Publicado: (2019)

State of the Globe: Antimicrobial Stewardship Guides Rationale Use of Antimicrobials to Enable Faster Cure and Prevent Drug Resistance
por: Kelkar, Dhanashree, et al.
Publicado: (2013)

Autoantibodies to neurotransmitter receptors and ion channels: from neuromuscular to neuropsychiatric disorders
por: Martinez-Martinez, Pilar, et al.
Publicado: (2013)

Computational drug repurposing in the age of COVID-19: mixing antiviral cocktails in silico
por: Diao, James A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eqcm2qqbg6mek57somvgacbm4e